An effort to more comprehensively determine the genetic factors associated with prostate-specific antigen (PSA) levels, and to develop and apply prediction models for prostate cancer outcomes based on genetically-adjusted PSA levels throughout life.
Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels – DUPLICATED DO NOT ACTIVATE
Investigator: Van Den Eeden, Stephen
Funder: National Cancer Institute
